(Q35842573)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Causality assessment in drug-induced hepatotoxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Raquel Camargo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

M Isabel Lucena

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Rocío González-Grande

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

329-344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

Drug-induced hepatotoxicity.

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Incidence of drug-induced hepatic injuries: a French population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Epidemiology and individual susceptibility to adverse drug reactions affecting the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Accuracy of hepatic adverse drug reaction reporting in one English health region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Drug-induced hepatic disorders. Incidence, management and avoidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish Board of Adverse Reactions to Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Acute hepatitis induced by greater celandine (Chelidonium majus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

21 January 2018

Herbal hepatotoxicity

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Drug-induced liver injury: mechanisms and test systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Association of acetaminophen hepatotoxicity with fasting and ethanol use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Tolerance after liver transplantation: does it exist and can immunosuppression be withdrawn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

The rational use of potentially hepatotoxic medications in patients with underlying liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Chronic hepatitis C, ibuprofen, and liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Effects of long-term rifampicin administration in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Antidepressant-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Impaired oxidation of debrisoquine in patients with perhexiline liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Possible association between poor metabolism of mephenytoin and hepatotoxicity caused by Atrium, a fixed combination preparation containing phenobarbital, febarbamate and difebarbamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Co-amoxiclav jaundice: clinical and histological features and HLA class II association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Association study designs for complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Ischemic hepatitis: clinical presentation and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

"Did this drug cause my patient's hepatitis?" and related questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Drug-induced liver disorders: implications for drug development and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Cirrhosis with steatohepatitis after adjuvant tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Bentazepam-associated chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Hepatotoxic effects of the anabolic/androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Trovafloxacin-induced acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Fatal hepatitis and renal failure during treatment with nimesulide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Benzylpenicillin-induced prolonged cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Fatal hepatitis associated with nimesulide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

The natural history of histologically proved drug induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Minocycline and Lupuslike Syndrome in Acne Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.4.329

21 January 2018

Identifiers

DOI

10.1517/14740338.3.4.329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15268650%20AND%20SRC:MED&resulttype=core&format=json

release_xmto6yeppbbsndsw2uh7swbtue

31 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xmto6yeppbbsndsw2uh7swbtue

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference